Gender-related differences in beta-adrenergic receptor-mediated cardiac remodeling

Baoling Zhu,Kai Liu,Chengzhi Yang,Yuhui Qiao,Zijian Li
DOI: https://doi.org/10.1139/cjpp-2016-0103
2016-01-01
Canadian Journal of Physiology and Pharmacology
Abstract:Cardiac remodeling is the pathological basis of various cardiovascular diseases. In this study, we found gender-related differences in beta-adrenergic receptor (AR)-mediated pathological cardiac remodeling. Cardiac remodeling model was established by subcutaneous injection of isoprenaline (ISO) for 14 days. Heart rate (HR), mean arterial pressure (MAP), and echocardiography were obtained on 7th and 14th days during ISO administration. Myocardial cross-sectional area and the ratio of heart mass to tibia length (HM/TL) were detected to assess cardiac hypertrophy. Picro-Sirius red staining (picric acid + Sirius red F3B) was used to evaluate cardiac fibrosis. Myocardial capillary density was assessed by immunohistochemistry for von Willebrand factor. Further, real-time PCR was used to measure the expression of beta 1-AR and beta 2-AR. Results showed that ISO induced cardiac remodeling, the extent of which was different between female and male mice. The extent of increase in cardiac wall thickness, myocardial cross-sectional area, and collagen deposition in females was less than that in males. However, no gender-related difference was observed in HR, MAP, cardiac function, and myocardial capillary density. The distinctive decrease of beta 2-AR expression, rather than a decrease of beta 1-AR expression, seemed to result in gender-related differences in cardiac remodeling.
What problem does this paper attempt to address?